Evidence map›Paper›PMID 29399513›Full record

ArticleJournal of visualized surgery2017

Thoracoscopic lobectomy after induction therapy-a paradigm shift?

Sameer A Hirji, Asishana Osho, Stafford S Balderson, Thomas A D'Amico

Open access · hybridAbstract read
In one paragraph

Article in Journal of visualized surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. [Results of N1 and N2 surgery in non-small cell lung cancer].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sameer A HirjiDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Asishana OshoDepartment of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Stafford S BaldersonDepartment of Surgery, Duke University Medical Center, Durham, NC, USA.
Thomas A D'AmicoDepartment of Surgery, Duke University Medical Center, Durham, NC, USA.
Duke Medical Center · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Video-assisted thoracoscopic approaches (or VATS) have gained significant momentum in the management of locally advanced NSCLC in the current era. Accrual of experiences and concurrent improvements in instrumentation and video technology have further enhanced its role in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC). However, substantial controversy exists around the notion of mediastinal staging and restaging after induction therapy, the utility of induction chemotherapy versus chemoradiation for N2 disease, and subsequent role of video-assisted thoracoscopic surgery (VATS) lobectomy following induction therapy. This perspective will closely examine these issues in the context of existing guidelines and contemporary studies.

Indexed as

induction therapylobectomyThoracoscopy/video-assisted thoracoscopic surgery (VATS)

Identifiers

PMID29399513
PMCPMC5765266
OpenAlexW2776285747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.